Group revenue for the FY2020 grew 8.8% y-o-y to $568.2 million as the group pivoted to meet the needs of the evolving healthcare situation amid Covid-19.
Raffles Medical Group (RMG) has reported earnings of $65.9 million for the FY2020 ended December, 9.3% higher than earnings of $60.3 million a year ago.
This brings earnings per share (EPS) to 3.58 cents, from FY2019’s 3.32 cents.

